Jefferies Group LLC Amarin Corp Plcuk Call Options Transaction History

Jefferies Group LLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Sep 21, 2023	SELL	$5.03 - $8.8 $94,564 - $165,440	-18,800 Reduced 5.52%	321,600 $2 Million
Q1 2021 May 14, 2021	SELL	$5.03 - $8.8 $94,564 - $165,440	-18,800 Reduced 5.52%	321,600 $2 Million
Q4 2020 Sep 21, 2023	BUY	$4.04 - $5.31 $1.38 Million - $1.81 Million	340,400 New	340,400 $1.66 Million
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $321,412 - $685,208	-88,300 Reduced 20.6%	340,400 $1.43 Million
Q2 2020 Nov 02, 2020	BUY	$4.78 - $8.26 $2.05 Million - $3.54 Million	428,700 New	428,700 $2.97 Million
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $3.5 Million - $6.04 Million	-731,300 Closed	0 $0
Q1 2020 Nov 24, 2020	BUY	$4.0 - $21.53 $2.93 Million - $15.7 Million	731,300 New	731,300 $9.93 Million
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $1.6 Million - $8.59 Million	-399,200 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $3.99 Million - $6.9 Million	285,900 Added 252.34%	399,200 $8.56 Million
Q3 2019 Nov 13, 2019	BUY	$13.89 - $23.16 $412,533 - $687,852	29,700 Added 35.53%	113,300 $1.72 Million
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $5.66 Million - $7.13 Million	-347,600 Reduced 80.61%	83,600 $1.62 Million
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $4.55 Million - $8.07 Million	361,200 Added 516.0%	431,200 $8.95 Million
Q4 2018 Feb 14, 2019	SELL	$12.41 - $22.98 $24.6 Million - $45.5 Million	-1,980,000 Reduced 96.59%	70,000 $953,000
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $5.02 Million - $33.4 Million	2,050,000 New	2,050,000 $33.4 Million

184

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $246M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.